Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100045011Phase 4Recruiting
Phase 4, randomised trial of remifentanil and propofol in None (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Remedial analgesia rate. Started Apr 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100045011.